Phase 3 RSV Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Pfizer550 enrolled97 locationsNCT06866405
Recruiting
Phase 3
A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
Respiratory Syncytial Virus (RSV)
Pfizer130 enrolled5 locationsNCT07543380
Recruiting
Phase 3
Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination
RSV Immunization
Centre Hospitalier Annecy Genevois1,000 enrolled1 locationNCT07232706
Recruiting
Phase 3
A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.
preterm labourRSV ImmunisationRSV Infections
University of Witwatersrand, South Africa13,000 enrolled11 locationsNCT06955728
Recruiting
Phase 3
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
Respiratory Syncytial Virus (RSV)
MAXVAX Biotechnology Limited Liability Company25,000 enrolled8 locationsNCT07272434
Recruiting
Phase 3
RSV Immunogenicity Study in the Elderly (RISE)
RSV Immunisation
Karin Karin Loré65 enrolled2 locationsNCT07203365